Form EFFECT Indaptus Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 17, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SES and Air Astana Introduce Multi-orbit Inflight Connectivity on A321LR Fleet
- Guardian Roofing, Gutters & Insulation Wins Prestigious 2026 BBB Torch Award for Ethics, Reinforcing Its Position as a Pacific Northwest Industry Leader
- Walmart and Base Power Announce a Strategic Agreement to Bring Affordable Home Backup Power and Energy Savings to Customers
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share